Moderna: 'strategic' collaboration with Generation Bio
(CercleFinance.com) - Moderna yesterday announced a "strategic" collaboration with Generation Bio, a biotech company innovating genetic medicines for people with rare and prevalent diseases, to combine Moderna's biological and technical expertise with the core technologies of Generation Bio's non-viral genetic medicine platform.
The collaboration aims to develop novel nucleic acid-based therapies so that the companies can expand their respective non-viral genetic drug pipelines.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
The collaboration aims to develop novel nucleic acid-based therapies so that the companies can expand their respective non-viral genetic drug pipelines.
Copyright (c) 2023 CercleFinance.com. All rights reserved.